RxDoctor Payments Data

Robert Molnar, MD

Vascular Surgery · Flint, MINPI 1770554248

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.3% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $199 and has fallen 52.1% since, to $95 in 2024. That places this record below the midpoint for vascular surgery clinicians in MI, where the typical reported total is $3,966.

$425in general payments, 2019–2025

Across 16 payments — averaging $26.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$93
  • Bard Peripheral Vascular, Inc.$57
  • Shockwave Medical, Inc$52
  • Philips North America LLC$51
  • Cook Medical LLC$36
  • Silk Road Medical, Inc.$27
  • plus $109 from 6 others
$53,601in research payments, 2019–2025

Across 33 payments — averaging $1624.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$26K
  • Merit Medical Systems Inc$16K
  • Endologix LLC$6K
  • C. R. Bard, Inc. & Subsidiaries$4K
  • Sonavex, Inc.$3K

What the payments were for

  • Food & beverage$40595%
  • Education$205%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$425 in reported general payments places this provider in the 15th percentile of 183 vascular surgery providers in Michigan.

See all vascular surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$536,145
Medicare patients
801
Services billed
6,568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$13,737
ClopidogrelClopidogrel Bisulfate43$723
Atorvastatin Calcium30$505

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →